53499-5864 NDC - UMCKA COUGH (UMCKA COUGH)

Drug Information

Product NDC: 53499-5864

Proprietary Name: Umcka Cough

Non Proprietary Name: UMCKA COUGH

Active Ingredient(s):
  • 3 [hp_X]/120mL ACONITUM NAPELLUS;
  • 3 [hp_X]/120mL BRYONIA ALBA ROOT;
  • 6 [hp_C]/120mL CALCIUM SULFIDE;
  • 1 [hp_X]/120mL PELARGONIUM SIDOIDES ROOT;
  • 3 [hp_X]/120mL SPONGIA OFFICINALIS SKELETON, ROASTED;
  • 6 [hp_C]/120mL TIN


Administration Route(s): ORAL

Dosage Form(s): SYRUP

Labeler Information

Labeler Name: Schwabe North America, Inc.
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:10/1/2012

Package Information

No. Package Code Package Description Billing Unit
153499-5864-41 BOTTLE in 1 BOX (53499-5864-4) / 120 mL in 1 BOTTLE

NDC Record

Field Name Field Value Definition
PRODUCT NDC53499-5864The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEUmcka CoughThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
PROPRIETARY NAME SUFFIXACONITUM NAPELLUS, BRYONIA ALBA ROOT, CALCIUM SULFIDE, SPONGIA OFFICINALIS SKELETON, ROASTED , TIN, PELARGONIUM SIDOIDES ROOTA suffix to the proprietary name, a value here should be appended to the ProprietaryName field to obtain the complete name of the product. This suffix is often used to distinguish characteristics of a product such as extended release (“XR”) or sleep aid (“PM”). Although many companies follow certain naming conventions for suffices, there is no recognized standard.
NON PROPRIETARY NAMEUMCKA COUGHThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMESYRUPThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE10/1/2012This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMESchwabe North America, Inc.Name of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEACONITUM NAPELLUS; BRYONIA ALBA ROOT; CALCIUM SULFIDE; PELARGONIUM SIDOIDES ROOT; SPONGIA OFFICINALIS SKELETON, ROASTED; TINAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH3; 3; 6; 1; 3; 6 
ACTIVE INGRED UNIT[hp_X]/120mL; [hp_X]/120mL; [hp_C]/120mL; [hp_X]/120mL; [hp_X]/120mL; [hp_C]/120mL 

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 2/1/2023